Micro/Nanobubbles (MNBs) for Treatment of Acute and Chronic Wounds
Part of paid clinical trials in Orange, California.
- Sponsor
- University of California, Irvine
- Study ID
- NCT05169814
- Phase
- EARLY_PHASE1
- Status
- Recruiting
Conditions
- Open Wound
- Wound Heal
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Micro/nanobubble (MNB) - Irrigation — DRUGAn MNB solution will be used as an irrigation solution to improve wound oxygenation in ischemic tissue (e.g. ischemic surgical tissue, traumatic wounds, and failing replants). The MNB solution will be used in wet-to-dry wound care dressings with daily scheduled dressing changes.
- 0.9% Normal Saline - Irrigation — OTHERA normal saline solution will be used as an irrigation solution to improve wound oxygenation in ischemic tissue (e.g. ischemic surgical tissue, traumatic wounds, and failing replants). The normal saline solution will be used in wet-to-dry wound care dressings with daily scheduled dressing changes.
- Micro/nanobubble (MNB) - Negative Pressure Wound Therapy with Instillation (NPWTi) — DRUGNPWTi with MNB will be applied to the wound with 20-minute instillation periods every 3 hours (standard instillation settings) with dressing changes every 3-5 days.
- 0.9% Normal Saline - Negative Pressure Wound Therapy with Instillation (NPWTi) — OTHERNPWTi with normal saline will be applied to the wound with 20-minute instillation periods every 3 hours (standard instillation settings) with dressing changes every 3-5 days.
Study Details
The purpose of this study is to assess the safety and efficacy of Micro/nanobubbles (MNB's) for the healing of acute and chronic wounds.
Key Dates
- Start date
- Oct 9, 2021
- Status verified
- Jun 2025
- Primary completion
- Jun 1, 2026
- Completion
- Jun 1, 2027
Study Design
- Enrollment
- 40 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Placebo Comparator: Acute Wounds - ControlThis arm will include patients with acute wounds and will receive standard of care: irrigation with normal saline.
- Experimental: Acute Wounds - ExperimentalThis arm will include patients with acute wounds and will receive experimental treatment: irrigation with micro/nanobubbles (MNB's) in normal saline.
- Placebo Comparator: Chronic Wounds - ControlThis arm will include patients with chronic wounds and will receive standard of care: negative pressure wound therapy with instillation (NPWTi) using normal saline.
- Experimental: Chronic Wounds - ExperimentalThis arm will include patients with chronic wounds and will receive experimental treatment: negative pressure wound therapy with instillation (NPWTi) using micro/nanobubbles (MNB's) in normal saline.
Primary Outcome Measure
Wound total oxygen saturation level [ Time Frame: 2-4 weeks ]
Central Contacts
- Leonardo Alaniz, BBA602-318-7118
- Lohrasb R Sayadi, MD949-209-7267
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| UCI Medical Center | Orange | California | 92868 |
Find similar trials in Orange, CA
By research site
Related Studies
- IDEAL: Efficacy of Porcine Placental Extracellular Matrix Augmented Plus Standard of Care (SOC) Versus SOC Alone for the Management of Diabetic Foot UlcersRecruiting · ConvaTec Inc. · Los Angeles, California
- Tissue Repair Gel in Venous Leg Ulcers (US)PHASE3 · Recruiting · TR Therapeutics · Tucson, Arizona
- EDX110 Randomized Control Trial for Treatment of DFUsRecruiting · ConvaTec Inc. · Phoenix, Arizona
- Microsurfaced Grafts in Deep Burn WoundsPHASE4 · Recruiting · CellTherX · Augusta, Georgia